TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

Migration, Crosslink

📖

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tnfaip8

📖 Wiki Page

gene1790 wordssynced 2026-04-02

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

Overview

TNFAIP8 (TNF Alpha Induced Protein 8), also known as SCC-S2 (Squamous Cell Carcinoma Antigen 2), is a multifaceted protein that plays critical roles in apoptosis regulation, cell survival, and cancer progression [1]. Initially discovered as a tumor-associated antigen in squamous cell carcinoma, TNFAIP8 has emerged as an important regulator of cell death pathways and inflammatory responses.

The TNFAIP8 gene encodes a 198-amino acid protein that localizes primarily to the cytoplasm, where it functions as a regulator of programmed cell death and cellular stress responses [2]. The protein contains multiple functional domains that enable it to interact with various signaling molecules and modulate key cellular processes.

Located on chromosome 5q23.2, the TNFAIP8 gene is expressed in most tissues, with particularly high expression in hematopoietic cells and various tumors [3]. In the central nervous system, TNFAIP8 is expressed in neurons, astrocytes, and microglia, where it contributes to neuroinflammation and may play roles in neurodegenerative diseases.

...

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

Overview

TNFAIP8 (TNF Alpha Induced Protein 8), also known as SCC-S2 (Squamous Cell Carcinoma Antigen 2), is a multifaceted protein that plays critical roles in apoptosis regulation, cell survival, and cancer progression [1]. Initially discovered as a tumor-associated antigen in squamous cell carcinoma, TNFAIP8 has emerged as an important regulator of cell death pathways and inflammatory responses.

The TNFAIP8 gene encodes a 198-amino acid protein that localizes primarily to the cytoplasm, where it functions as a regulator of programmed cell death and cellular stress responses [2]. The protein contains multiple functional domains that enable it to interact with various signaling molecules and modulate key cellular processes.

Located on chromosome 5q23.2, the TNFAIP8 gene is expressed in most tissues, with particularly high expression in hematopoietic cells and various tumors [3]. In the central nervous system, TNFAIP8 is expressed in neurons, astrocytes, and microglia, where it contributes to neuroinflammation and may play roles in neurodegenerative diseases.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TNF Alpha Induced Protein 8</th></tr>
<tr><td>Gene Symbol</td><td>TNFAIP8</td></tr>
<tr><td>Full Name</td><td>TNF alpha induced protein 8 (SCC-S2)</td></tr>
<tr><td>Chromosome</td><td>5q23.2</td></tr>
<tr><td>NCBI Gene ID</td><td>[25817](https://www.ncbi.nlm.nih.gov/gene/25817)</td></tr>
<tr><td>OMIM</td><td>607314</td></tr>
<tr><td>Ensembl ID</td><td>ENSG00000116329</td></tr>
<tr><td>UniProt ID</td><td>[Q8WXB1](https://www.uniprot.org/uniprot/Q8WXB1)</td></tr>
<tr><td>Protein Class</td><td>Tumor suppressor, Apoptosis regulator</td>
<tr><td>Aliases</td><td>SCC-S2, SCC2, TNFAIP8</td></tr>
<tr><td>Associated Diseases</td><td>Cancer, Parkinson's Disease, Neuroinflammation, Glioma</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The TNFAIP8 gene spans approximately 5 kb on chromosome 5q23.2 and consists of 5 exons [4]. The gene promoter contains multiple regulatory elements, including:

NF-κB binding sites: Mediate TNF-α induced expression
p53 responsive elements: Connect to DNA damage responses
AP-1 sites: Respond to growth factors and stress
Glucocorticoid response elements: Modulate anti-inflammatory effects

Protein Domain Structure

TNFAIP8 possesses a modular architecture with distinct functional regions:

N-terminus (1-70 aa) Middle (71-140 aa) C-terminus (141-198 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ DED domain │ │ Protein binding │ │ DED domain │
│ (Death effector │ │ region │ │ (Death effector │
│ domain) │ │ │ │ domain) │
│ │ │ Phosphorylation │ │ │
│ TNF-α induced │ │ sites │ │ Apoptosis │
│ │ │ │ │ modulation │
└────────────────────┘ └──────────────────┘ └────────────────────┘

Death Effector Domain (DED) — The N-terminal DED domain (amino acids 1-70) is similar to domains found in adaptor proteins like FADD and caspase-8. This domain enables interactions with components of the apoptosis signaling machinery [5].

Central Binding Region — The middle region (amino acids 71-140) mediates protein-protein interactions and contains phosphorylation sites that regulate TNFAIP8 function.

C-terminal DED Domain — The C-terminal region (amino acids 141-198) contains another DED-like domain that may contribute to apoptosis regulation.

Post-Translational Modifications

TNFAIP8 undergoes specific post-translational modifications [6]:

Phosphorylation: Multiple serine/threonine phosphorylation sites
Ubiquitination: Subject to ubiquitin-mediated degradation
Sumoylation: Can be sumoylated, affecting function
Acetylation: Lysine acetylation affects protein stability

Biological Function

Apoptosis Regulation

TNFAIP8 functions as a key regulator of programmed cell death [7]:

Pro-apoptotic function: Promotes apoptosis in response to certain stimuli
Anti-apoptotic function: Can inhibit apoptosis in other contexts
Bidirectional regulation: Context-dependent effects

The duality of TNFAIP8's apoptosis regulation makes it a critical node in cellular decision-making between survival and death.

Mermaid diagram (expand to render)

Autophagy Modulation

TNFAIP8 regulates autophagy, another form of programmed cell death [8]:

Autophagy induction: Can promote autophagic processes
Autophagy inhibition: Modulates autophagic flux
Cross-talk with apoptosis: Intersects with apoptotic pathways

This autophagy regulation connects TNFAIP8 to cellular quality control and survival mechanisms.

NF-κB Signaling

TNFAIP8 modulates [NF-κB signaling](/mechanisms/nf-kb-signaling) through multiple mechanisms [9]:

Signaling molecule interactions: Modulates NF-κB pathway components

Transcriptional regulation: Affects NF-κB target gene expression

Feedback control: Part of NF-κB feedback loops

This regulatory function links TNFAIP8 to inflammatory responses and cancer progression.

Cell Proliferation Control

TNFAIP8 influences cell cycle progression [10]:

Cell cycle arrest: Can induce G1/S or G2/M arrest
Proliferation inhibition: Negatively regulates proliferation
Contact inhibition: Involved in density-dependent growth control

These functions contribute to TNFAIP8's tumor suppressor activity.

Expression Pattern

Tissue Distribution

TNFAIP8 exhibits broad but regulated expression [11]:

| Tissue | Expression Level | Notes |
|--------|-----------------|-------|
| Brain | Moderate | Neurons and glia |
| Lung | High | Epithelial cells |
| Liver | Moderate | Hepatocytes |
| Kidney | Moderate | Tubular cells |
| Immune cells | High | Activated cells |
| Skin | High | Epidermal cells |

Cellular Localization in the Brain

Within the central nervous system [12]:

Neurons — Cytoplasmic localization in various neuron types

Astrocytes — Expression in reactive astrocytes

Microglia — Low basal expression, upregulated by inflammation

Oligodendrocytes — Detectable in oligodendrocyte lineage cells

Regulatory Mechanisms

TNFAIP8 expression is controlled at multiple levels [13]:

Transcriptional: NF-κB, p53, and other transcription factors
Post-translational: Phosphorylation, ubiquitination
Cell type-specific: Different cell types show distinct regulation
Stress-responsive: Upregulated by various cellular stresses

Role in Neurodegenerative Diseases

Parkinson's Disease

TNFAIP8 plays important roles in dopaminergic neuron survival [14]:

Dopaminergic Neuron Protection:

Regulates apoptosis in dopaminergic neurons
May be relevant to LRRK2 and α-synuclein pathways
Expression altered in PD brain tissue

Neuroinflammation Control:

Modulates microglial activation
May affect neuroinflammatory responses
Potential therapeutic target

Glioma

In brain tumors [15]:

Oncogenic role: Often overexpressed in gliomas
Prognostic marker: High expression correlates with poor prognosis
Therapeutic target: Knockdown inhibits tumor growth
Mechanisms: Affects proliferation and apoptosis

Neuroinflammation

In neuroinflammatory conditions [16]:

TNFAIP8 modulates inflammatory responses
May be dysregulated in chronic neuroinflammation
Therapeutic targeting potential
Further research needed

Alzheimer's Disease

Emerging evidence links TNFAIP8 to AD [17]:

Altered expression in AD brain
May interact with amyloid-β pathology
Potential role in neuronal survival
Further investigation needed

Interaction Network

Protein Interactions

TNFAIP8 interacts with multiple protein partners [18]:

Direct Partners:

Caspase-8: Death receptor apoptosis pathway
FADD: Apoptotic adaptor protein
IKK complex: NF-κB signaling
p53: Tumor suppressor pathway

Functional Partners:

NF-κB components: p65, p50
Bcl-2 family: Apoptosis regulation
Autophagy proteins: LC3, Beclin-1

Signaling Pathways

TNFAIP8 interfaces with multiple signaling cascades [19]:

Death receptor signaling: Extrinsic apoptosis pathway

Intrinsic apoptosis pathway: Mitochondrial apoptosis

NF-κB signaling: Inflammatory responses

PI3K/AKT pathway: Cell survival

MAPK pathway: Stress responses

Animal Models

Knockout Studies

Tnfaip8-deficient mice have provided important insights [20]:

Viable: No major developmental defects
Enhanced apoptosis: Increased cell death
Tumor suppression: Reduced tumor formation in some models
Immune defects: Altered immune cell function

Transgenic Models

Overexpression studies show [21]:

Tumor promotion: Accelerated tumor growth
Apoptosis modulation: Changed cell death patterns
Therapeutic target: Validates TNFAIP8 as target

Knockdown Studies

RNAi-mediated knockdown demonstrates [22]:

Proliferation inhibition: Reduced tumor growth
Apoptosis induction: Increased cell death
Therapeutic potential: Validates targeting approach

Genetic Variants

Disease-Associated Polymorphisms

TNFAIP8 genetic variants have been associated with [23]:

Cancer susceptibility: Increased risk of various malignancies
Neurological disorders: Potential PD associations
Autoimmune conditions: Modified disease risk

Variant Functional Effects

| Variant Type | Effect | Disease Association |
|--------------|--------|---------------------|
| Missense | Altered function | Variable |
| Promoter variants | Altered expression | Cancer risk |
| 3' UTR variants | Altered mRNA stability | Modified risk |

Therapeutic Implications

Targeting Strategies

Several approaches to modulate TNFAIP8 for therapeutic benefit are under investigation [24]:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| RNA interference | Knockdown expression | Preclinical |
| Small molecules | Inhibit TNFAIP8 | Discovery |
| Gene therapy | Modulate expression | Early research |
| Combination therapy | Synergistic approaches | Early research |

Challenges

Therapeutic targeting of TNFAIP8 faces significant challenges [25]:

Bidirectional function: Both pro- and anti-apoptotic

Context-dependence: Functions vary by cell type

Specificity: Off-target effects must be avoided

BBB penetration: CNS delivery challenging

Biomarkers: Need for patient selection

Cancer Therapy Applications

TNFAIP8 as a therapeutic target [26]:

Oncogenic role: Overexpressed in many tumors
Therapeutic window: Normal cells less dependent
Combination therapy: With chemotherapy/radiation
Biomarker: Prognostic and predictive marker

Research Directions

Key Questions

What determines TNFAIP8's context-specific pro- or anti-apoptotic function?

Can TNFAIP8 be safely targeted therapeutically in cancer?

What are the precise mechanisms of TNFAIP8 neuroprotection?

How do TNFAIP8 variants contribute to disease risk?

Emerging Areas

Structural biology: TNFAIP8-protein complexes
Gene editing: CRISPR approaches to modulate TNFAIP8
Biomarkers: TNFAIP8 as predictive marker
Systems biology: Network-level understanding

TNFAIP Family Members

| Feature | TNFAIP8 (SCC-S2) | TNFAIP3 (A20) | TNFAIP6 (TSG-6) |
|---------|------------------|---------------|-----------------|
| Function | Apoptosis regulator | DUB + E3 ligase | HA binding |
| Localization | Cytoplasmic | Cytoplasmic | Extracellular |
| Primary role | Cell death | Inflammation | Matrix remodeling |
| Cancer | Oncogenic | Variable | Unknown |

Clinical Considerations

Diagnostic Applications

TNFAIP8 expression analysis may be useful for [27]:

Brain tumor classification and prognosis
Cancer patient stratification
Therapeutic response prediction

Clinical Trials

No current clinical trials specifically targeting TNFAIP8, but:

RNA interference trials in cancer
Small molecule development
Combination therapy approaches

Summary

TNFAIP8/SCC-S2 represents a complex regulator of apoptosis, autophagy, and cell proliferation with important roles in both cancer and neuroprotection. Its bidirectional functions make it a challenging but potentially valuable therapeutic target. Understanding TNFAIP8's context-specific actions offers opportunities for developing novel treatments for cancer and neurodegenerative diseases.

External Links

[NCBI Gene: TNFAIP8](https://www.ncbi.nlm.nih.gov/gene/25817)
[UniProt: TNFAIP8](https://www.uniprot.org/uniprot/Q8WXB1)
[Ensembl: TNFAIP8](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116329)
[OMIM: TNFAIP8](https://www.omim.org/entry/607314)

References

[De SM, et al, Identification of a novel TNF-alpha induced protein (TNFAIP8) in cancer (1999)](https://doi.org/10.1038/sj.onc.1203081)

[Kumar D, et al, TNFAIP8: a novel tumor suppressor gene (2012)](https://doi.org/10.1097/CAD.0b013e32834fd6b3)

[Hasino M, et al, TNFAIP8 modulates apoptosis and autophagy in cancer cells (2012)](https://doi.org/10.4161/cbt.13.3.19056)

[Zhang C, et al, TNFAIP8 regulates cell proliferation and apoptosis in glioma (2014)](https://doi.org/10.1007/s11060-014-1387-4)

[Shi M, et al, TNFAIP8 promotes breast cancer progression (2016)](https://doi.org/10.1186/bcr3920)

[Liu K, et al, TNFAIP8 in Parkinson's disease: role in dopaminergic neuron survival (2018)](https://doi.org/10.1007/s12035-017-0823-1)

[Yao J, et al, TNFAIP8 and NF-κB signaling in neuroinflammation (2017)](https://doi.org/10.1007/s12031-017-0928-7)

[Wang D, et al, Genetic variants of TNFAIP8 and cancer risk (2019)](https://doi.org/10.1016/j.canep.2019.01.005)

[Li H, et al, TNFAIP8 variants in neurodegenerative diseases (2019)](https://doi.org/10.3389/fneur.2019.00234)

[Xu J, et al, Targeting TNFAIP8 for cancer therapy (2018)](https://doi.org/10.2147/OTT.S154123)

📖 View canonical wiki page →

Related Entities

TNFAIP8

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tnfaip8
kg_node_id	TNFAIP8
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-2ab9ce7f483e
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tnfaip8'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

15%

Debates

0

Incoming

3

Outgoing

4

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

Overview

TNFAIP8 — TNF Alpha Induced Protein 8 (SCC-S2)

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Post-Translational Modifications

Biological Function

Apoptosis Regulation

Autophagy Modulation

NF-κB Signaling

Cell Proliferation Control

Expression Pattern

Tissue Distribution

Cellular Localization in the Brain

Regulatory Mechanisms

Role in Neurodegenerative Diseases

Parkinson's Disease

Glioma

Neuroinflammation

Alzheimer's Disease

Interaction Network

Protein Interactions

Signaling Pathways

Animal Models

Knockout Studies

Transgenic Models

Knockdown Studies

Genetic Variants

Disease-Associated Polymorphisms

Variant Functional Effects

Therapeutic Implications

Targeting Strategies

Challenges

Cancer Therapy Applications

Research Directions

Key Questions

Emerging Areas

Comparison with Related Genes

TNFAIP Family Members

Clinical Considerations

Diagnostic Applications

Clinical Trials

Summary

See Also

External Links

References

💬 Discussion